Product
Migalastat
Aliases
Galafold®
Name
Galafold
INN Name
migalastat hydrochloride
FDA Approved
Yes
2 clinical trials
1 organization
1 indication
1 document
Indication
Fabry DiseaseClinical trial
A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular HypertrophyStatus: Recruiting, Estimated PCD: 2025-12-29
Clinical trial
An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects With Fabry Disease and Amenable GLA Variants and Severe Renal Impairment or End-Stage Renal Disease Treated With HemodialysisStatus: Recruiting, Estimated PCD: 2024-12-31
Document
DailyMed Label: GalafoldOrganization
Amicus Therapeutics US, LLC